Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Low-dose 5-aza-2'-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cells.

Chan MW, Chang CB, Tung CH, Sun J, Suen JL, Wu SF.

Mol Med. 2014 Jun 26;20:248-56. doi: 10.2119/molmed.2013.00159.

3.

Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.

Fissolo N, Costa C, Nurtdinov RN, Bustamante MF, Llombart V, Mansilla MJ, Espejo C, Montalban X, Comabella M.

J Neuroinflammation. 2012 Jun 22;9:139. doi: 10.1186/1742-2094-9-139.

4.

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.

Weber MS, Prod'homme T, Patarroyo JC, Molnarfi N, Karnezis T, Lehmann-Horn K, Danilenko DM, Eastham-Anderson J, Slavin AJ, Linington C, Bernard CC, Martin F, Zamvil SS.

Ann Neurol. 2010 Sep;68(3):369-83. doi: 10.1002/ana.22081.

5.

Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.

Chen SJ, Wang YL, Lo WT, Wu CC, Hsieh CW, Huang CF, Lan YH, Wang CC, Chang DM, Sytwu HK.

Clin Exp Immunol. 2010 Nov;162(2):210-23.

6.

Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis.

Matsushita T, Horikawa M, Iwata Y, Tedder TF.

J Immunol. 2010 Aug 15;185(4):2240-52. doi: 10.4049/jimmunol.1001307. Epub 2010 Jul 12.

8.
9.

Oestrogen-mediated protection of experimental autoimmune encephalomyelitis in the absence of Foxp3+ regulatory T cells implicates compensatory pathways including regulatory B cells.

Subramanian S, Yates M, Vandenbark AA, Offner H.

Immunology. 2011 Mar;132(3):340-7. doi: 10.1111/j.1365-2567.2010.03380.x. Epub 2010 Nov 23.

10.

T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.

Zheng H, Zhang H, Liu F, Qi Y, Jiang H.

Immunol Lett. 2014 Jan-Feb;157(1-2):38-44. doi: 10.1016/j.imlet.2013.11.001. Epub 2013 Nov 9.

PMID:
24220208
11.

Salmon proteoglycan suppresses progression of mouse experimental autoimmune encephalomyelitis via regulation of Th17 and Foxp3(+) regulatory T cells.

Sashinami H, Asano K, Yoshimura S, Mori F, Wakabayashi K, Nakane A.

Life Sci. 2012 Dec 17;91(25-26):1263-9. doi: 10.1016/j.lfs.2012.09.022. Epub 2012 Oct 12.

PMID:
23069584
12.

An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.

Choi JH, Lee MJ, Jang M, Kim EJ, Shim I, Kim HJ, Lee S, Lee SW, Kim YO, Cho IH.

PLoS One. 2015 Oct 7;10(10):e0138592. doi: 10.1371/journal.pone.0138592. eCollection 2015. Erratum in: PLoS One. 2015;10(10):e0141635.

13.

CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.

Villares R, Cadenas V, Lozano M, Almonacid L, Zaballos A, Martínez-A C, Varona R.

Eur J Immunol. 2009 Jun;39(6):1671-81. doi: 10.1002/eji.200839123.

14.

Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.

Liu JQ, Liu Z, Zhang X, Shi Y, Talebian F, Carl JW Jr, Yu C, Shi FD, Whitacre CC, Trgovcich J, Bai XF.

J Immunol. 2012 Apr 1;188(7):3099-106. doi: 10.4049/jimmunol.1100106. Epub 2012 Mar 2.

15.

Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.

Rynda-Apple A, Huarte E, Maddaloni M, Callis G, Skyberg JA, Pascual DW.

Eur J Immunol. 2011 Feb;41(2):313-23. doi: 10.1002/eji.201041104. Epub 2010 Dec 29.

16.

Modification of the FoxP3 transcription factor principally affects inducible T regulatory cells in a model of experimental autoimmune encephalomyelitis.

Verhagen J, Burton BR, Britton GJ, Shepard ER, Anderton SM, Wraith DC.

PLoS One. 2013 Apr 8;8(4):e61334. doi: 10.1371/journal.pone.0061334. Print 2013.

17.

Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.

Thomé R, Moraes AS, Bombeiro AL, Farias Ados S, Francelin C, da Costa TA, Di Gangi R, dos Santos LM, de Oliveira AL, Verinaud L.

PLoS One. 2013 Jun 14;8(6):e65913. doi: 10.1371/journal.pone.0065913. Print 2013.

18.

GCN2 kinase plays an important role triggering the remission phase of experimental autoimmune encephalomyelitis (EAE) in mice.

Orsini H, Araujo LP, Maricato JT, Guereschi MG, Mariano M, Castilho BA, Basso AS.

Brain Behav Immun. 2014 Mar;37:177-86. doi: 10.1016/j.bbi.2013.12.012. Epub 2013 Dec 21.

19.
20.

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.

Fransson M, Piras E, Burman J, Nilsson B, Essand M, Lu B, Harris RA, Magnusson PU, Brittebo E, Loskog AS.

J Neuroinflammation. 2012 May 30;9:112. doi: 10.1186/1742-2094-9-112.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk